Development and pilot study of “Smart Cancer Care”: a platform for managing side effects of chemotherapy

por Sin, Cheolkyung, Kim, Hyeyeong, Im, Hyeon-Su, Ock, Minsu, Koh, Su-Jin
Publicado 2023

The Validation Study of the Stress and Anxiety to Viral Epidemics−6 Scale Among Patients With Cancer in the COVID-19 Pandemic

por Kim, Hyeyeong, Kim, Harin, Lee, Hyuk Joo, Cho, Eulah, Koh, Su-Jin, Ahmed, Oli, Chung, Seockhoon
Publicado 2022

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma

por Cheon, Jaekyung, Kim, Hyeyeong, Kim, Han Sang, Kim, Chang Gon, Kim, Ilhwan, Kang, Beodeul, Kim, Chan, Jung, Sanghoon, Ha, Yeonjung, Chon, Hong Jae
Publicado 2023

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study

por Kim, Beom Kyung, Cheon, Jaekyung, Kim, Hyeyeong, Kang, Beodeul, Ha, Yeonjung, Kim, Do Young, Hwang, Seong Gyu, Chon, Young Eun, Chon, Hong Jae
Publicado 2022

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment

por Chon, Young Eun, Cheon, Jaekyung, Kim, Hyeyeong, Kang, Beodeul, Ha, Yeonjung, Kim, Do young, Hwang, Seong Gyu, Chon, Hong Jae, Kim, Beom Kyung
Publicado 2022

Association of High Levels of Antidrug Antibodies Against Atezolizumab With Clinical Outcomes and T-Cell Responses in Patients With Hepatocellular Carcinoma

por Kim, Chan, Yang, Hannah, Kim, Ilhwan, Kang, Beodeul, Kim, Hyeyeong, Kim, Hyunho, Lee, Won Suk, Jung, Sanghoon, Lim, Ho Yeong, Cheon, Jaekyung, Chon, Hong Jae
Publicado 2022

Changes in decision-making process for life-sustaining treatment in patients with advanced cancer after the life-sustaining treatment decisions-making act

por Kim, Hyeyeong, Im, Hyeon-Su, Lee, Kyong Og, Min, Young Joo, Jo, Jae-Cheol, Choi, Yunsuk, Lee, Yoo Jin, Kang, Daseul, Kim, Changyoung, Koh, Su-Jin, Cheon, Jaekyung
Publicado 2021

The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation

por Heo, Sook-Kyoung, Noh, Eui-Kyu, Lee, Yoo Jin, Shin, Yerang, Kim, Youjin, Im, Hyeon-Su, Kim, Hyeyeong, Koh, Su Jin, Min, Young Joo, Jo, Jae-Cheol, Choi, Yunsuk
Publicado 2022

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

por Yang, Hannah, Kang, Beodeul, Ha, Yeonjung, Lee, Sung Hwan, Kim, Ilhwan, Kim, Hyeyeong, Lee, Won Suk, Kim, Gwangil, Jung, Sanghoon, Rha, Sun Young, Gaillard, Vincent E., Cheon, Jaekyung, Kim, Chan, Chon, Hong Jae
Publicado 2023